Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08KZM
|
|||
| Former ID |
DIB010427
|
|||
| Drug Name |
CC49 humanized radioimmunoconjugates
|
|||
| Synonyms |
CC49 humanized radioimmunoconjugates, NCI, UAB; CC49 humanized radioimmunoconjugates, National Cancer Institute, University of Alabama at Birmingham; HuCC49deltaCH2, NCI, UAB; HuCC49deltaCH2, National Cancer Institute, University of Alabama at Birmingham
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
National Cancer Institute
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Technology evaluation: CC49 humanized radioimmunoconjugates, National Cancer Institute. Curr Opin Mol Ther. 2003 Aug;5(4):428-32. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.